Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
ISME J ; 17(6): 846-854, 2023 06.
Article in English | MEDLINE | ID: mdl-36949153

ABSTRACT

The rise of ß-lactam resistance among pathogenic bacteria, due to the horizontal transfer of plasmid-encoded ß-lactamases, is a current global health crisis. Importantly, ß-lactam hydrolyzation by ß-lactamases, not only protects the producing cells but also sensitive neighboring cells cooperatively. Yet, how such cooperative traits affect plasmid transmission and maintenance is currently poorly understood. Here we experimentally show that KPC-2 ß-lactamase expression and extracellular activity were higher when encoded on plasmids compared with the chromosome, resulting in the elevated rescue of sensitive non-producers. This facilitated efficient plasmid transfer to the rescued non-producers and expanded the potential plasmid recipient pool and the probability of plasmid transfer to new genotypes. Social conversion of non-producers by conjugation was efficient yet not absolute. Non-cooperative plasmids, not encoding KPC-2, were moderately more competitive than cooperative plasmids when ß-lactam antibiotics were absent. However, in the presence of a ß-lactam antibiotic, strains with non-cooperative plasmids were efficiently outcompeted. Moreover, plasmid-free non-producers were more competitive than non-producers imposed with the metabolic burden of a plasmid. Our results suggest that cooperative antibiotic resistance especially promotes the fitness of replicons that transfer horizontally such as conjugative plasmids.


Subject(s)
Bacteria , Drug Resistance, Microbial , Gene Transfer, Horizontal , Gene Transfer, Horizontal/drug effects , Gene Transfer, Horizontal/genetics , Drug Resistance, Microbial/drug effects , Drug Resistance, Microbial/genetics , Plasmids/drug effects , Plasmids/genetics , beta-Lactamases/genetics , beta-Lactamases/metabolism , Genotype , Conjugation, Genetic , Chromosomes, Bacterial/genetics , beta-Lactams/pharmacology , Anti-Bacterial Agents/pharmacology , Bacteria/cytology , Bacteria/drug effects , Bacteria/genetics
2.
Sci Rep ; 12(1): 21503, 2022 12 13.
Article in English | MEDLINE | ID: mdl-36513721

ABSTRACT

Drug-loaded electrospun nanofibers are potential drug carrier systems that may optimize disease treatment while reducing the impact on commensal microbes. The feasibility of streptomycin-loaded pullulan nanofibers fabricated from a green electrospinning procedure using water as the solvent was assessed. We conducted a rat study including a group treated with streptomycin-loaded nanofibers (STR-F, n = 5), a group treated with similar concentrations of streptomycin in the drinking water (STR-W, n = 5), and a non-treated control group (CTR, n = 5). Streptomycin was successfully loaded into nanofibers and delivered by this vehicle, which minimized the quantity of the drug released in the ileal compartment of the gut. Ingested streptomycin-resistant E. coli colonized of up to 106 CFU/g feces, revealing a selective effect of streptomycin even when given in the low amounts allowed by the nanofiber-based delivery. 16S amplicon sequencing of the indigenous microbiota revealed differential effects in the three groups. An increase of Peptostreptococcaceae in the cecum of STR-F animals may indicate that the fermentation of nanofibers directly or indirectly promoted growth of bacteria within this family. Our results elucidate relevant properties of electrospun nanofibers as a novel vehicle for delivery of antimicrobials to the large intestine.


Subject(s)
Nanofibers , Rats , Animals , Streptomycin/pharmacology , Escherichia coli , Drug Carriers , Colon , Drug Delivery Systems/methods
3.
Gut Microbes ; 14(1): 2084306, 2022.
Article in English | MEDLINE | ID: mdl-36519447

ABSTRACT

AbstarctIn fecal microbiota transplantation (FMT) against recurrent Clostridioides difficile infection (CDI), clinical outcomes are usually determined after 8 weeks. We hypothesized that the intestinal microbiota changes earlier than this timepoint, and analyzed fecal samples obtained 1 week after treatment from 64 patients diagnosed with recurrent CDI and included in a randomized clinical trial, where the infection was treated with either vancomycin-preceded FMT (N = 24), vancomycin (N = 16) or fidaxomicin (N = 24). In comparison with non-responders, patients with sustained resolution after FMT had increased microbial alpha diversity, enrichment of Ruminococcaceae and Lachnospiraceae, depletion of Enterobacteriaceae, more pronounced donor microbiota engraftment, and resolution of gut microbiota dysbiosis. We found that a constructed index, based on markers for the identified genera Escherichia and Blautia, successfully predicted clinical outcomes at Week 8, which exemplifies a way to utilize clinically feasible methods to predict treatment failure. Microbiota changes were restricted to patients who received FMT rather than antibiotic monotherapy, indicating that FMT confers treatment response in a different way than antibiotics. We suggest that early identification of microbial community structures after FMT is of clinical value to predict response to the treatment.


Subject(s)
Clostridioides difficile , Clostridium Infections , Gastrointestinal Microbiome , Humans , Fecal Microbiota Transplantation/methods , Clostridioides difficile/physiology , Vancomycin/therapeutic use , Clostridium Infections/therapy , Treatment Outcome , Anti-Bacterial Agents/therapeutic use
4.
Microbiome ; 10(1): 193, 2022 11 10.
Article in English | MEDLINE | ID: mdl-36352460

ABSTRACT

BACKGROUND: Fecal microbiota transplantation (FMT) effectively prevents the recurrence of Clostridioides difficile infection (CDI). Long-term engraftment of donor-specific microbial consortia may occur in the recipient, but potential further transfer to other sites, including the vertical transmission of donor-specific strains to future generations, has not been investigated. Here, we report, for the first time, the cross-generational transmission of specific bacterial strains from an FMT donor to a pregnant patient with CDI and further to her child, born at term, 26 weeks after the FMT treatment. METHODS: A pregnant woman (gestation week 12 + 5) with CDI was treated with FMT via colonoscopy. She gave vaginal birth at term to a healthy baby. Fecal samples were collected from the feces donor, the mother (before FMT, and 1, 8, 15, 22, 26, and 50 weeks after FMT), and the infant (meconium at birth and 3 and 6 months after birth). Fecal samples were profiled by deep metagenomic sequencing for strain-level analysis. The microbial transfer was monitored using single nucleotide variants in metagenomes and further compared to a collection of metagenomic samples from 651 healthy infants and 58 healthy adults. RESULTS: The single FMT procedure led to an uneventful and sustained clinical resolution in the patient, who experienced no further CDI-related symptoms up to 50 weeks after treatment. The gut microbiota of the patient with CDI differed considerably from the healthy donor and was characterized as low in alpha diversity and enriched for several potential pathogens. The FMT successfully normalized the patient's gut microbiota, likely by donor microbiota transfer and engraftment. Importantly, our analysis revealed that some specific strains were transferred from the donor to the patient and then further to the infant, thus demonstrating cross-generational microbial transfer. CONCLUSIONS: The evidence for cross-generational strain transfer following FMT provides novel insights into the dynamics and engraftment of bacterial strains from healthy donors. The data suggests FMT treatment of pregnant women as a potential strategy to introduce beneficial strains or even bacterial consortia to infants, i.e., neonatal seeding. Video Abstract.


Subject(s)
Clostridioides difficile , Clostridium Infections , Adult , Female , Humans , Infant, Newborn , Pregnancy , Bacteria , Clostridium Infections/therapy , Clostridium Infections/microbiology , Fecal Microbiota Transplantation/methods , Feces/microbiology , Recurrence , Treatment Outcome
5.
Dalton Trans ; 51(17): 6899-6907, 2022 May 03.
Article in English | MEDLINE | ID: mdl-35441633

ABSTRACT

Titanium dioxide (TiO2) has attracted enormous interest in abundant photocatalytic reactions, but its photocatalytic efficiency is limited by its wide bandgap and the rapid recombination of electron-hole pairs. To overcome the disadvantages of its rapid electron-hole recombination rate, herein, oxidative TiO2 was one-step fabricated using potassium permanganate (KMnO4), exhibiting improved charge separation efficiency and photocatalytic degradation performance towards methyl orange (MO). Remarkably, the first-order photodegradation rate of oxidative TiO2 is 3.68 times higher than that of pristine TiO2 under the irradiation of simulated sunlight and 2.15 times higher under ultraviolet light. This exceptional photocatalytic activity is attributed to the additional oxygen doped into the interstices of the TiO2 lattice, creating impurity states in the bandgap acting as trapping sites, thus facilitating charge separation. This work provides a promising strategy for the insertion of O atoms into the TiO2 lattice and expands the photocatalytic application of the related materials.

6.
Ecol Lett ; 25(1): 189-201, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34749426

ABSTRACT

Artificial selection of microbiota opens new avenues for improving plants. However, reported results lack consistency. We hypothesised that the success in artificial selection of microbiota depends on the stabilisation of community structure. In a ten-generation experiment involving 1,800 plants, we selected rhizosphere microbiota of Brachypodium distachyon associated with high or low leaf greenness, a proxy of plant performance. The microbiota structure showed strong fluctuations during an initial transitory phase, with no detectable leaf greenness heritability. After five generations, the microbiota structure stabilised, concomitantly with heritability in leaf greenness. Selection, initially ineffective, did successfully alter the selected property as intended, especially for high selection. We show a remarkable correlation between the variability in plant traits and selected microbiota structures, revealing two distinct sub-communities associated with high or low leaf greenness, whose abundance was significantly steered by directional selection. Understanding microbiota structure stabilisation will improve the reliability of artificial microbiota selection.


Subject(s)
Microbiota , Rhizosphere , Phenotype , Reproducibility of Results , Soil Microbiology
7.
Gut Microbes ; 14(1): 2005407, 2022.
Article in English | MEDLINE | ID: mdl-34965188

ABSTRACT

Type 2 diabetes (T2D) management is based on combined pharmacological and lifestyle intervention approaches. While their clinical benefits are well studied, less is known about their effects on the gut microbiota. We aimed to investigate if an intensive lifestyle intervention combined with conventional standard care leads to a different gut microbiota composition compared to standard care alone treatment in individuals with T2D, and if gut microbiota is associated with the clinical benefits of the treatments. Ninety-eight individuals with T2D were randomized to either an intensive lifestyle intervention combined with standard care group (N = 64), or standard care alone group (N = 34) for 12 months. All individuals received standardized, blinded, target-driven medical therapy, and individual counseling. The lifestyle intervention group moreover received intensified physical training and dietary plans. Clinical characteristics and fecal samples were collected at baseline, 3-, 6-, 9-, and 12-month follow-up. The gut microbiota was profiled with 16S rRNA gene amplicon sequencing. There were no statistical differences in the change of gut microbiota composition between treatments after 12 months, except minor and transient differences at month 3. The shift in gut microbiota alpha diversity at all time windows did not correlate with the change in clinical characteristics, and the gut microbiota did not mediate the treatment effect on clinical characteristics. The clinical benefits of intensive lifestyle and/or pharmacological interventions in T2D are unlikely to be explained by, or causally related to, changes in the gut microbiota composition.


Subject(s)
Diabetes Mellitus, Type 2/diet therapy , Diabetes Mellitus, Type 2/psychology , Gastrointestinal Microbiome , Life Style , Adult , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/microbiology , Diet , Exercise , Feces/microbiology , Female , Follow-Up Studies , Humans , Male , Middle Aged
8.
Appl Environ Microbiol ; 87(11)2021 05 11.
Article in English | MEDLINE | ID: mdl-33741632

ABSTRACT

Assessing "dysbiosis" in intestinal microbial communities is increasingly considered a routine analysis in microbiota studies, and it has added relevant information to the prediction and characterization of diseases and other adverse conditions. However, dysbiosis is not a well-defined condition. A variety of different dysbiosis indexes have been suggested and applied, but their underlying methodologies, as well as the cohorts and conditions for which they have been developed, differ considerably. To date, no comprehensive overview and comparison of all the different methodologies and applications of such indexes is available. Here, we list all types of dysbiosis indexes identified in the literature, introduce their methodology, group them into categories, and discuss their potential descriptive and clinical applications as well as their limitations. Thus, our focus is not on the implications of dysbiosis for disease but on the methodological approaches available to determine and quantify this condition.


Subject(s)
Diagnostic Tests, Routine/methods , Dysbiosis/diagnosis , Gastrointestinal Microbiome/physiology , Dysbiosis/microbiology , Humans
9.
Front Microbiol ; 10: 3010, 2019.
Article in English | MEDLINE | ID: mdl-31998278

ABSTRACT

The capacity of microbes to degrade recalcitrant materials has been extensively explored for environmental remediation and industrial production. Significant achievements have been made with single strains, but focus is now going toward the use of microbial consortia owning to their functional stability and efficiency. However, assembly of simplified microbial consortia (SMC) from complex environmental communities is still far from trivial due to large diversity and the effect of biotic interactions. Here we propose a strategy, based on enrichment and dilution-to-extinction cultures, to construct SMC with reduced diversity for degradation of keratinous materials. Serial dilutions were performed on a keratinolytic microbial consortium pre-enriched from a soil sample, monitoring the dilution effect on community growth and enzymatic activities. An appropriate dilution regime (10-9) was selected to construct a SMC library from the enriched microbial consortium. Further sequencing analysis and keratinolytic activity assays demonstrated that obtained SMC displayed actual reduced microbial diversity, together with various taxonomic composition, and biodegradation capabilities. More importantly, several SMC possessed equivalent levels of keratinolytic efficiency compared to the initial consortium, showing that simplification can be achieved without loss of function and efficiency. This methodology is also applicable to other types of recalcitrant material degradation involving microbial consortia, thus considerably broadening its application scope.

10.
EBioMedicine ; 38: 265-272, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30478001

ABSTRACT

BACKGROUND: Macrolides are commonly prescribed for respiratory infections and asthma-like episodes in children. While their clinical benefits have been proved, concerns regarding the side-effects of their therapeutic use have been raised. Here we assess the short- and long-term impacts of azithromycin on the gut microbiota of young children. METHODS: We performed a randomized, double-blind, placebo-controlled trial in a group of children aged 12-36 months, diagnosed with recurrent asthma-like symptoms from the COPSAC2010 cohort. Each acute asthma-like episode was randomized to a 3-day course of azithromycin oral solution of 10 mg/kg per day or placebo. Azithromycin reduced episode duration by half, which was the primary end-point and reported previously. The assessment of gut microbiota after treatment was the secondary end-point and reported in this study. Fecal samples were collected 14 days after randomization (N = 59, short-term) and again at age 4 years (N = 49, long-term, of whom N = 18 were placebo treated) and investigated by 16S rRNA gene amplicon sequencing. FINDINGS: Short-term, azithromycin caused a 23% reduction in observed richness and 13% reduction in Shannon diversity. Microbiota composition was shifted primarily in the Actinobacteria phylum, especially a reduction of abundance in the genus Bifidobacterium. Long-term (13-39 months after treatment), we did not observe any differences between the azithromycin and placebo recipients in their gut microbiota composition. INTERPRETATION: Azithromycin treatment induced a perturbation in the gut microbiota 14 days after randomization but did not have long-lasting effects on the gut microbiota composition. However, it should be noted that our analyses included a limited number of fecal samples for the placebo treated group at age 4 years. FUND: Lundbeck Foundation, Danish Ministry of Health, Danish Council for Strategic Research, Capital Region Research Foundation, China Scholarship Council.


Subject(s)
Anti-Bacterial Agents/pharmacology , Azithromycin/pharmacology , Gastrointestinal Microbiome/drug effects , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Biodiversity , Child, Preschool , Female , Humans , Infant , Male , Metagenome , Metagenomics , Time Factors
11.
Plant Cell Rep ; 36(9): 1507-1518, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28660363

ABSTRACT

KEY MESSAGE: A fresh look at the roles of auxin, ethylene, and polar auxin transport during the plant root growth response to warmer ambient temperature (AT). The ambient temperature (AT) affects plant growth and development. Plants can sense changes in the AT, but how this change is transduced into a plant root growth response is still relatively unclear. Here, we found that the Arabidopsis ckrc1-1 mutant is sensitive to higher AT. At 27 °C, the ckrc1-1 root length is significantly shortened and the root gravity defect is enhanced, changes that can be restored with addition of 1-naphthaleneacetic acid, but not indole-3-acetic acid (IAA). AUX1, PIN1, and PIN2 are involved in the ckrc1-1 root gravity response under increased AT. Furthermore, CKRC1-dependent auxin biosynthesis was critical for maintaining PIN1, PIN2, and AUX1 expression at elevated temperatures. Ethylene was also involved in this regulation through the ETR1 pathway. Higher AT can promote CKRC1-dependent auxin biosynthesis by enhancing ETR1-mediated ethylene signaling. Our research suggested that the interaction between auxin and ethylene and that the interaction-mediated polar auxin transport play important roles during the plant root growth response to higher AT.


Subject(s)
Arabidopsis/metabolism , Plant Growth Regulators/metabolism , Plant Roots/metabolism , Temperature , Adaptation, Physiological/drug effects , Adaptation, Physiological/genetics , Arabidopsis/genetics , Arabidopsis/growth & development , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Ethylenes/metabolism , Ethylenes/pharmacology , Gene Expression Regulation, Developmental , Gene Expression Regulation, Plant , Indoleacetic Acids/metabolism , Indoleacetic Acids/pharmacology , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Mutation , Naphthaleneacetic Acids/metabolism , Naphthaleneacetic Acids/pharmacology , Plant Growth Regulators/pharmacology , Plant Roots/genetics , Plant Roots/growth & development
12.
Sci Rep ; 5: 11923, 2015 Jul 06.
Article in English | MEDLINE | ID: mdl-26143750

ABSTRACT

Identification of mutants with impairments in auxin biosynthesis and dynamics by forward genetic screening is hindered by the complexity, redundancy and necessity of the pathways involved. Furthermore, although a few auxin-deficient mutants have been recently identified by screening for altered responses to shade, ethylene, N-1-naphthylphthalamic acid (NPA) or cytokinin (CK), there is still a lack of robust markers for systematically isolating such mutants. We hypothesized that a potentially suitable phenotypic marker is root curling induced by CK, as observed in the auxin biosynthesis mutant CK-induced root curling 1 / tryptophan aminotransferase of Arabidopsis 1 (ckrc1/taa1). Phenotypic observations, genetic analyses and biochemical complementation tests of Arabidopsis seedlings displaying the trait in large-scale genetic screens showed that it can facilitate isolation of mutants with perturbations in auxin biosynthesis, transport and signaling. However, unlike transport/signaling mutants, the curled (or wavy) root phenotypes of auxin-deficient mutants were significantly induced by CKs and could be rescued by exogenous auxins. Mutants allelic to several known auxin biosynthesis mutants were re-isolated, but several new classes of auxin-deficient mutants were also isolated. The findings show that CK-induced root curling provides an effective marker for discovering genes involved in auxin biosynthesis or homeostasis.


Subject(s)
Cytokinins/metabolism , Indoleacetic Acids/metabolism , Plant Growth Regulators/biosynthesis , Arabidopsis/enzymology , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Biological Transport/drug effects , Indoleacetic Acids/pharmacology , Mutation , Phenotype , Plant Roots/enzymology , Plant Roots/genetics , Plant Roots/growth & development , Seedlings/drug effects , Seedlings/growth & development , Seedlings/metabolism , Signal Transduction/drug effects , Tryptophan Transaminase/genetics , Tryptophan Transaminase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...